GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, according to research presented at the annual meeting of the European Association of Nuclear Medicine (EANM) being held in Barcelona, Spain.
These drugs are now…
GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, according to research presented at the annual meeting of the European Association of Nuclear Medicine (EANM) being held in Barcelona, Spain.
These drugs are now…